ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
康休
65.60
+0.0000
成交量:
- -
成交額:
- -
市值:
127.60億
市盈率:
-1.26
高:
65.60
開:
65.60
低:
65.60
收:
65.60
資料載入中...
總覽
公司
新聞
公告
港股收評:恒生指數漲1.74% 恒生科技指數漲3.08%
美港电讯
·
05-02
收評:港股恒指漲1.74% 科指漲3.08% CXO概念股大漲
新浪港股
·
05-02
CXO風向標強勢歸來,藥明康德一季度實現雙位數增長
国际金融报
·
04-29
CXO概念走勢亮眼!藥明康德A、H股跳漲,業績表現如何?
财华社
·
04-29
突發跳水,什麼情況?愛博醫療20CM跌停帶崩板塊!藥明康德率CXO龍頭力挽狂瀾
市场资讯
·
04-23
港股異動 | CRO概念午後走低 美對華關閉核心生物數據庫 關稅對CXO及上游目前影響較為有限
智通财经
·
04-08
里昂:內地CXO及創新藥物表現亮麗 調整醫藥股目標價(表)
智通财经
·
04-08
Particle Network、Haedal Protocol出席“OKX Web3 Night”
Odaily
·
04-07
港股異動 | CRO概念股跌幅居前 機構稱關稅對CXO及上游目前影響較為有限 關注生物安全法案相關進展
智通财经
·
04-07
CXO企業國內營收集體“首降” 五大龍頭淨利潤全線下滑 拐點漸顯至暗時刻已過?
新浪证券
·
04-03
A股收評:三大指數小幅收漲 全市場成交額不足萬億元
美港电讯
·
04-02
現金方式收購CXO企業 賬上錢夠嗎?成都先導回應
美港电讯
·
04-01
現金方式收購CXO企業,賬上錢夠嗎?成都先導回應
21世纪经济报道
·
04-01
港股異動 | CRO概念股漲幅居前 全鏈條支持創新藥發展政策逐步落地 機構稱有望拉動CXO需求
智通财经
·
04-01
地量震盪,什麼原因?化工板塊領跌,券商護盤未果!CXO突然變臉,醫療ETF(512170)溢價仍走高
市场资讯
·
03-28
業績向好,CXO復甦進程開啓?藥明康德、康龍化成聯袂大漲 醫療ETF(512170)放量漲1.18% 尾盤溢價飆升
市场资讯
·
03-27
久違了,“吃藥喝酒”行情,CXO強勢助攻!AI芯片點火,科創人工智能ETF華寶(589520)盤中衝擊3%!
市场资讯
·
03-27
【港股CXO板塊集體走強,藥明康德漲超4%】維亞生物漲超7%,昭衍新藥、藥明生物漲超6%,康龍化成、藥明康德漲超4%,泰格醫藥、凱萊英漲超3%,金斯瑞生物科技漲超2%。
金融界
·
03-27
業績揭曉,康龍化成勁漲3%,CXO概念集體反彈!醫療ETF(512170)拉昇翻紅,此前5日大舉吸金6.3億元!
市场资讯
·
03-27
藥明生物(02269)年報觀:“低估值+高成長”,全球CXO龍頭估值亟待強修復
智通财经
·
03-25
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CXO/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CXO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CXO\",,,,,undefined,":{"symbol":"CXO","market":"US","secType":"STK","nameCN":"康休","latestPrice":65.6,"timestamp":1610744400000,"preClose":65.6,"halted":4,"volume":0,"delay":0,"floatShares":192489259,"shares":194506801,"eps":-52.266872,"marketStatus":"退市","change":0,"latestTime":"05-05 06:52:22 EDT","open":65.6,"high":65.6,"low":65.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-52.266872,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1746451800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1186113600000,"exchange":"NYSE","adjPreClose":65.6,"dividendRate":0.011052,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CXO\",,,,,undefined,":{"symbol":"CXO","floatShares":192489259,"roa":"-30.69%","roe":"-77.91%","lyrEps":-3.548023,"shares":194506801,"dividePrice":0.725,"high":65.6,"amplitude":0,"preClose":65.6,"low":65.6,"week52Low":33.13,"pbRate":"1.64","week52High":90.52,"institutionHeld":0,"latestPrice":65.6,"eps":-52.266872,"divideRate":0.011052,"volume":0,"delay":0,"ttmEps":-52.266872,"open":65.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CXO\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532891279","title":"港股收評:恒生指數漲1.74% 恒生科技指數漲3.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532891279","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532891279?lang=zh_tw&edition=fundamental","pubTime":"2025-05-02 16:14","pubTimestamp":1746173673,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0348735423.USD","HBBD.SI","LU0456827905.SGD","89618","HHImain","01024","09863","02833","MCHmain","80992","00992","HSImain","80700","02150","01810","513600","BABA","YANG","HSTECH","HSI","CXO","81810","BILI","TCEHY","LU0106259558.USD","XIACY","BK4505","LU1196710195.USD","LU0886674414.USD","89988","81024","MHImain","LU0541501648.USD","BK4558","07226","JD","LU1568876251.USD","09618","HSCEI","HXXD.SI","LU1813983027.USD","IE0003851619.USD","HTCD.SI","00700","LNVGY","09626","CXO.AU","LU2097828714.EUR","09988","IE00B067MR52.USD"],"gpt_icon":0},{"id":"2532914858","title":"收評:港股恒指漲1.74% 科指漲3.08% CXO概念股大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2532914858","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532914858?lang=zh_tw&edition=fundamental","pubTime":"2025-05-02 16:10","pubTimestamp":1746173400,"startTime":"0","endTime":"0","summary":" 5月2日消息,港股三大指数高开高走,截至收盘,恒生指数涨1.74%,报22504.68点,恒生科技指数涨3.08%,国企指数涨1.92%。盘面上,科网股全线上涨,小米集团涨超6%,阿里巴巴、京东集团涨超3%,快手、联想集团、哔哩哔哩、腾讯控股涨超2%;新能源车企股集体走高,零跑汽车涨超7%;CXO概念股整体大涨,药明康德涨超7%;新茶饮股集体上行,奈雪的茶涨超8%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-05-02/doc-ineveeay4963077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HSI","513600","HHImain","MCHmain","MHImain","BK4614","CXO","HSImain","02833","YANG","HSCEI","HSTECH"],"gpt_icon":1},{"id":"2531736117","title":"CXO風向標強勢歸來,藥明康德一季度實現雙位數增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2531736117","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531736117?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 20:17","pubTimestamp":1745929065,"startTime":"0","endTime":"0","summary":"4月28日盘后,一向被视作医药外包(CXO)行业风向标的药明康德发布了2025年第一季度业绩报告。财务信息显示,药明康德今年第一季度实现营收96.54亿元,同比增长20.96%;归母净利润36.72亿元,同比增长89.06%。这是药明康德近三年来首次在第一季度交出双位数增长的“成绩单”。受此消息影响,截至4月29日收盘,药明康德A股报收60.45元,涨4.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504293393172334.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504293393172334.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CXO","BK1576","LU0052750758.USD","LU0320764599.SGD","BK1141","LU2045819591.USD","BK1583","LU0708995583.HKD","LU1046422090.SGD","LU2242644610.SGD","LU2125910500.SGD","02359"],"gpt_icon":0},{"id":"2531222483","title":"CXO概念走勢亮眼!藥明康德A、H股跳漲,業績表現如何?","url":"https://stock-news.laohu8.com/highlight/detail?id=2531222483","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531222483?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 15:09","pubTimestamp":1745910542,"startTime":"0","endTime":"0","summary":"4月29日,医药外包龙头药明康德(603259.SH,02359.HK)表现不俗,其A股一度跳空大涨6%,其H股更是一度跳涨逾7%。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202504_1/73958931-afdd-42a1-a35f-ebbd2c4bc72b.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202504_1/73958931-afdd-42a1-a35f-ebbd2c4bc72b.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/68107b0e2308293f38408bcc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["02359","BK1141","CXO","BK1583","BK1576","LU0052750758.USD","LU1046422090.SGD","LU2045819591.USD","LU2125910500.SGD","LU0320764599.SGD","LU0708995583.HKD","LU2242644610.SGD"],"gpt_icon":0},{"id":"2529350290","title":"突發跳水,什麼情況?愛博醫療20CM跌停帶崩板塊!藥明康德率CXO龍頭力挽狂瀾","url":"https://stock-news.laohu8.com/highlight/detail?id=2529350290","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529350290?lang=zh_tw&edition=fundamental","pubTime":"2025-04-23 20:13","pubTimestamp":1745410380,"startTime":"0","endTime":"0","summary":"4月23日,医疗板块高开低走,中证医疗指数全天在水面附近盘整。主要拖累是此前活跃的医械股,其中以爱博医疗最为典型——跳空低开,20CM跌停。昨日,爱博医疗披露2024年年报及2025年一季报,公司2024年营业收入约14.1亿元,同比增加48.24%;归母净利润约3.88亿元,同比增加27.77%。但今年一季度,营业收入3.57亿元,同比增长15.07%;归母净利润9255.81万元,同比下降10.05%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-04-23/doc-ineueerq3049609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02359","LU2125910500.SGD","603259","688050","BK1583","BK1576","LU0708995583.HKD","LU1997244956.HKD","LU1997245094.SGD","BK0251","BK0216","LU2045819591.USD","LU0052750758.USD","LU2488822045.USD","LU0320764599.SGD","LU2495084118.USD","LU1046422090.SGD","BK1141","LU2242644610.SGD","CXO","LU1997245177.USD","LU2460026573.USD","LU0456842615.SGD"],"gpt_icon":0},{"id":"2525834023","title":"港股異動 | CRO概念午後走低 美對華關閉核心生物數據庫 關稅對CXO及上游目前影響較為有限","url":"https://stock-news.laohu8.com/highlight/detail?id=2525834023","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525834023?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 14:23","pubTimestamp":1744093425,"startTime":"0","endTime":"0","summary":"该行指出,国内CXO行业目前在研发阶段主要以研发服务形式对美出口,属于免关税。而目前多数商业化阶段订单,国内企业仅完成至N-2或者N-1阶段,随后转移至欧洲等地完成最后的合成步骤,因此目前仍属于免关税,整体影响较为有限。国内“对等关税”出台预计同样对行业整体影响较小。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1275274.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","BK1576","BK1583","BK1141","CXO","03759","06127"],"gpt_icon":0},{"id":"2525882399","title":"里昂:內地CXO及創新藥物表現亮麗 調整醫藥股目標價(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525882399","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525882399?lang=zh_tw&edition=fundamental","pubTime":"2025-04-08 11:12","pubTimestamp":1744081932,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,里昂发布研报称,重新检视了数家内地医药外包(CXO)、中药、创新药物以及医疗服务公司的去年下半年及第四季业绩。整体而言,内地CXO及创新药物表现亮丽,中药维持稳定,而医疗服务公司需要时间恢复。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1275160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03692","06078","06821","159938","01177","CXO","159992","01951","03759","06978","09939"],"gpt_icon":0},{"id":"2525063861","title":"Particle Network、Haedal Protocol出席“OKX Web3 Night”","url":"https://stock-news.laohu8.com/highlight/detail?id=2525063861","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525063861?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 13:52","pubTimestamp":1744005174,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 据官方消息,“OKX Web3 Night”活动于 4 月 6 日正式开启,现场气氛火热。Particle Network/UniversalX CXO Lydia 、Haedal 创始人 Luke,以及 OKX 全球首席商务官 Lennix 出席了活动,围绕《距离全民 Web3,还有多远?》主题,展开了一场深度圆桌对话。\nLuke 表示,TGE 对项目来说是构建社区,增长用户的重要机会。但从 DeFi 项目的整个生命周期来看,TGE 只是开始使用 tokenomics 构建完整产品的“成人时刻”。有坚实产品和强大营收的项目将获得市场认可和公允定价。此外,Luke 透露,Haedal protocol 将于四月 TGE。Lydia 认为,所有有真正 PMF 的 DApp 都值得用链抽象的方式再做一遍。UniversalX 会与 OKX 钱包一同探索非托管前提下的最优多链用户体验。\n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/426072?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["CXO.AU","BK7504","CXO","PMF","BK7095"],"gpt_icon":0},{"id":"2525036363","title":"港股異動 | CRO概念股跌幅居前 機構稱關稅對CXO及上游目前影響較為有限 關注生物安全法案相關進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2525036363","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525036363?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 10:03","pubTimestamp":1743991390,"startTime":"0","endTime":"0","summary":"本次美国对中国加征关税中,药品暂不涉及。该行指出,国内CXO行业目前在研发阶段主要以研发服务形式对美出口,属于免关税。国内“对等关税”出台预计同样对行业整体影响较小。西南证券指出,CXO关注生物安全法案相关进展。中泰国际此前表示,美国在今年出台的《2025财年国防授权法案》中暂未提及生物安全法案,根据近期在医药行业的多方了解,按目前情况预计2025年内出台生物安全法案的可能性不高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1274420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","06127","CXO","03759","03347","01873","BK1576","BK1583"],"gpt_icon":0},{"id":"2524018864","title":"CXO企業國內營收集體“首降” 五大龍頭淨利潤全線下滑 拐點漸顯至暗時刻已過?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524018864","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524018864?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 13:50","pubTimestamp":1743659400,"startTime":"0","endTime":"0","summary":" 2024年,中国CXO行业交出了一份并不理想的成绩单。药明康德、康龙化成、泰格医药、凯莱英、博腾股份五大头部企业净利润全线下滑。 泰格医药营收同比下降超10%,归母净利润、扣非净利润分别下滑79.99%、42.13%,均创下历史最大跌幅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-04-03/doc-inerwmtp8492751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CXO"],"gpt_icon":0},{"id":"2524349433","title":"A股收評:三大指數小幅收漲 全市場成交額不足萬億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524349433","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524349433?lang=zh_tw&edition=fundamental","pubTime":"2025-04-02 15:04","pubTimestamp":1743577466,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK7504","399001","BK0264","399300","159982","BK0054","002006","161121","605228","BK0034","399006","BK0251","603072","159940","BK0214","BK0102","CXO.AU","BK1128","603178","BK7095","CXO","BK0064","01981","BK0077"],"gpt_icon":0},{"id":"2524134642","title":"現金方式收購CXO企業 賬上錢夠嗎?成都先導回應","url":"https://stock-news.laohu8.com/highlight/detail?id=2524134642","media":"美港电讯","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524134642?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 12:56","pubTimestamp":1743483375,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1515","BK1161","159938","09939","BK0216","CXO","CXO.AU","BK7504","BK1574","688222","BK7095"],"gpt_icon":0},{"id":"2524132571","title":"現金方式收購CXO企業,賬上錢夠嗎?成都先導回應","url":"https://stock-news.laohu8.com/highlight/detail?id=2524132571","media":"21世纪经济报道","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524132571?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 12:51","pubTimestamp":1743483060,"startTime":"0","endTime":"0","summary":"3月31日晚间,成都先导公告称,公司正在筹划以现金方式受让股权的方式合计取得南京海纳医药科技股份有限公司约65%的股权。目前,成都先导与海纳医药尚未就收购的具体方案、最终股权比例、交易价格、业绩承诺等达成一致意见,收购尚处于筹划阶段。成都先导预计将于6个月内披露交易的预案或正式方案。截至4月1日早盘收盘,成都先导涨12.07%,报17.36元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-04-01/doc-inerrtfn7385403.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-04-01/doc-inerrtfn7385403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CXO","BK0216","688222"],"gpt_icon":0},{"id":"2524180722","title":"港股異動 | CRO概念股漲幅居前 全鏈條支持創新藥發展政策逐步落地 機構稱有望拉動CXO需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2524180722","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524180722?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 11:02","pubTimestamp":1743476525,"startTime":"0","endTime":"0","summary":"中信建投此前指出,近年来在ADC、多肽药物快速发展下,相关CXO需求迅速增加,小核酸、CGT等细分领域也有望迎来快速发展。长期仍看好CXO板块发展潜力及成长空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1272405.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348825331.USD","LU0979878070.USD","02269","159992","LU0348735423.USD","LU1720050803.USD","LU0052750758.USD","03759","IE00B0JY6N72.USD","CXO","LU0140636845.USD","LU0417516902.SGD","LU0572944931.SGD","LU0516422440.USD","LU1242518931.SGD","LU2039709279.SGD","SG9999002562.SGD","BK1161","LU1242518857.USD","LU0516422952.EUR","LU0516423091.SGD","LU0051755006.USD","LU1688375341.USD","BK1610","BK1141","BK1574","LU0326950275.SGD","LU0359201612.USD","BK1589","LU0823426480.USD","LU0856984785.SGD","LU0043850808.USD","LU0456827905.SGD","BK1191","06127","LU0307460666.USD","06821","LU0708995583.HKD","BK1521","LU0039217434.USD","BK1576","LU0320764599.SGD","LU0823426308.USD","LU0588546209.SGD","LU0456846285.SGD","LU0417516738.SGD","LU0181495838.USD","LU0516422366.SGD","LU1880383366.USD","06978"],"gpt_icon":1},{"id":"2522764625","title":"地量震盪,什麼原因?化工板塊領跌,券商護盤未果!CXO突然變臉,醫療ETF(512170)溢價仍走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2522764625","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522764625?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 20:23","pubTimestamp":1743164580,"startTime":"0","endTime":"0","summary":"周五,A股再续调整,三大指数跌幅均超0.5%,全市场缩量成交1.15万亿元,单日成交额创2月以来新低。化工板块领跌,化工ETF场内跌1.27%。CXO掉头向下,引发医药医疗冲高回落,医疗ETF场内跌0.87%。券商板块午后一度直线拉升翻红,终究难敌抛压,券商ETF平盘报收。 【CXO突然变脸,泰格医药绩后重挫6.6%! A股普跌影响下,医疗板块震荡走低,医疗ETF早盘一度逆市翻红,而后持续下行,场内收跌0.87%,振幅超2%,成交5.84亿元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-03-28/doc-inerfitm1180488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159828","CXO","512170"],"gpt_icon":0},{"id":"2522301714","title":"業績向好,CXO復甦進程開啓?藥明康德、康龍化成聯袂大漲 醫療ETF(512170)放量漲1.18% 尾盤溢價飆升","url":"https://stock-news.laohu8.com/highlight/detail?id=2522301714","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522301714?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 21:33","pubTimestamp":1743082380,"startTime":"0","endTime":"0","summary":"3月27日,医疗板块在CXO强力带动下震荡走高,医疗ETF早盘成功翻红,午后高位盘整,场内收涨1.18%,全天振幅达2.65%,放量成交6亿元。 值得关注的是,尾盘医疗ETF溢价走阔,反映买盘资金尤为强势。而此前5日已有资金连续进场,累计净申购逾6.3亿元。 成份股表现来看,CXO概念股涨幅居前,昭衍新药、博腾股份涨超5%领涨板块,泰格医药、康龙化成涨超4%,巨头药明康德涨3.44%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-03-27/doc-inerceui7893938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02359","LU2125910500.SGD","603259","BK1583","BK1576","LU0708995583.HKD","LU1997245094.SGD","300759","03759","BK0216","LU2045819591.USD","LU0052750758.USD","512170","LU2488822045.USD","LU0320764599.SGD","LU1046422090.SGD","BK1141","159828","LU2242644610.SGD","CXO","LU1997245177.USD","LU0456842615.SGD"],"gpt_icon":0},{"id":"2522301075","title":"久違了,“吃藥喝酒”行情,CXO強勢助攻!AI芯片點火,科創人工智能ETF華寶(589520)盤中衝擊3%!","url":"https://stock-news.laohu8.com/highlight/detail?id=2522301075","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522301075?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 21:32","pubTimestamp":1743082320,"startTime":"0","endTime":"0","summary":"三大指数早盘联袂拉涨,午后横盘运行,均以红盘报收。权重股回暖,核心龙头宽基A50ETF华宝跑赢大市。 盘面上,“吃药喝酒”行情久违再现! 半导体芯片全线走强,芯原股份、力合微等AI芯片龙头领头飙升,科创人工智能ETF华宝盘中冲击3%!重点布局国产AI产业链的科创人工智能ETF华宝场内价格今日再涨1.42%,斩获日线2连阳!上交所数据显示,科创人工智能ETF华宝近10日累计吸金5233万元!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-03-27/doc-inerceui7893562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CXO","588730"],"gpt_icon":0},{"id":"2522731276","title":"【港股CXO板塊集體走強,藥明康德漲超4%】維亞生物漲超7%,昭衍新藥、藥明生物漲超6%,康龍化成、藥明康德漲超4%,泰格醫藥、凱萊英漲超3%,金斯瑞生物科技漲超2%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2522731276","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522731276?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 14:55","pubTimestamp":1743058528,"startTime":"0","endTime":"0","summary":"维亚生物涨超7%,昭衍新药、药明生物涨超6%,康龙化成、药明康德涨超4%,泰格医药、凯莱英涨超3%,金斯瑞生物科技涨超2%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c1d06c6940354aa092ba4cb0febc291a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/27145549081529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1610","LU0819121731.USD","LU1146622755.USD","LU2242644610.SGD","01548","BK1589","LU0516422952.EUR","CXO","LU0348735423.USD","LU1720050803.USD","HSCEI","LU0039217434.USD","LU2488822045.USD","LU0979878070.USD","06821","LU1794554557.SGD","300347","LU0456827905.SGD","BK0239","LU1820825898.SGD","LU1997245177.USD","BK1191","LU0516423091.SGD","01873","LU2039709279.SGD","LU1688375341.USD","LU0051755006.USD","HK0000306685.HKD","BK1583","BK4614","LU0043850808.USD","LU0572944931.SGD","LU1046422090.SGD","02269","03759","03347","002821","LU0456846285.SGD","LU1997245094.SGD","BK1576","300759","YANG","603259","LU0181495838.USD","02359","603127","BK0077","06127","HSTECH"],"gpt_icon":0},{"id":"2522971763","title":"業績揭曉,康龍化成勁漲3%,CXO概念集體反彈!醫療ETF(512170)拉昇翻紅,此前5日大舉吸金6.3億元!","url":"https://stock-news.laohu8.com/highlight/detail?id=2522971763","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522971763?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 11:29","pubTimestamp":1743046140,"startTime":"0","endTime":"0","summary":"3月27日早盘,医疗板块盘中拉升,医疗ETF成功翻红,成份股中CXO概念股涨幅居前,博腾股份涨超6%领涨板块,昭衍新药涨4%了, 泰格医药、康龙化成涨超3%。 近期医疗资金面热度攀升,数据显示,此前5个交易日,医疗ETF场内连续申赎净流入,金额合计超6.3亿元。 消息面,康龙化成最新公布2024年年报,公司营业收入122.8亿元,同比上升6.4%;归母净利润17.9亿元,同比上升12%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-03-27/doc-ineraiqq4036116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["512170","BK1141","CXO","300759","03759","159828","BK1576","BK0216"],"gpt_icon":0},{"id":"2522247700","title":"藥明生物(02269)年報觀:“低估值+高成長”,全球CXO龍頭估值亟待強修復","url":"https://stock-news.laohu8.com/highlight/detail?id=2522247700","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522247700?lang=zh_tw&edition=fundamental","pubTime":"2025-03-25 19:53","pubTimestamp":1742903616,"startTime":"0","endTime":"0","summary":"2024年,全球多数头部CXO公司陆续下调了业绩指引,但即便如此最终达成年初业绩指引的也只是少数。在此业绩导向下,药明生物在2025年回归高增速增长的确定性明显提高,公司估值有望实现强修复并回到正常增长轨道,预计2025年整体收入增长12-15%。此外,药明生物在2024年下半年PPQ先导指标回归高增长,全年完成16个PPQ项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1267400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348825331.USD","LU0326950275.SGD","CXO","LU2039709279.SGD","LU0979878070.USD","LU0417516902.SGD","LU0320764599.SGD","LU1880383366.USD","BK1141","LU0456827905.SGD","LU0140636845.USD","02269","LU0516422440.USD","LU0307460666.USD","LU0456846285.SGD","LU0052750758.USD","LU1720050803.USD","LU0327786744.USD","LU1794554557.SGD","BK1521","SG9999002562.SGD","LU0051755006.USD","LU0516422952.EUR","LU0181495838.USD","IE00B0JY6N72.USD","LU1688375341.USD","LU0417516738.SGD","BK1610","LU0359202008.SGD","LU1242518931.SGD","LU0823426480.USD","LU0572944931.SGD","LU0359201612.USD","LU0823426308.USD","LU0043850808.USD","LU0856984785.SGD","BK1589","LU0588546209.SGD","LU0708995583.HKD","LU0348735423.USD","LU1242518857.USD","BK1576","LU0039217434.USD","LU0819121731.USD","LU0516423091.SGD","LU0516423174.USD","SG9999002463.SGD","LU0516422366.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":69,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CXO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-01-19","symbol":"CXO","reason":null,"defaultRemindTime":1611066600000,"announcedDate":"2021-01-14","type":"delisting","dateTimestamp":1611032400000},{"market":"US","date":"2020-11-05","symbol":"CXO","amount":0.2,"defaultRemindTime":1604586600000,"name":"康休","payableDate":"2020-11-06","currency":"USD","type":"dividend","dateTimestamp":1604552400000},{"market":"US","date":"2020-10-27","symbol":"CXO","fiscalQuarterEnding":"2020/09","expectedEps":1.14,"name":null,"time":"盤後","type":"earning","dateTimestamp":1603771200000,"reportTimeType":"post","actualEps":1.43},{"market":"US","date":"2020-08-06","symbol":"CXO","amount":0.2,"defaultRemindTime":1596720600000,"name":"康休","payableDate":"2020-08-07","currency":"USD","type":"dividend","dateTimestamp":1596686400000},{"market":"US","date":"2020-07-29","symbol":"CXO","fiscalQuarterEnding":"2020/06","expectedEps":0.33,"name":null,"time":"盤後","type":"earning","dateTimestamp":1595995200000,"reportTimeType":"post","actualEps":1.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CXO\",market:\"US\",,,undefined,":[{"executeDate":"2019-02-28","recordDate":null,"paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-05-09","recordDate":"2019-05-10","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-08-08","recordDate":"2019-08-09","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-11-07","recordDate":"2019-11-08","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2020-02-27","recordDate":"2020-02-28","paymentDate":null,"value":0.2,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CXO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CXO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CXO","date":"2021-01-15","current":-1.325388,"percent":0.244996,"low":-22.831021,"twenty":-14.937462,"median":17.448879,"eighty":43.624979,"high":142.858816,"avg":25.025998,"sd":38.430736,"marketCap":13577273687},"quantilePoints":[{"date":"2020-05-08","current":-1.232608,"twenty":-14.900412,"median":29.923023,"eighty":49.729928,"marketCap":11447230976},{"date":"2020-05-15","current":-1.140541,"twenty":-14.900412,"median":28.505604,"eighty":49.729928,"marketCap":10592202468},{"date":"2020-05-22","current":-1.173542,"twenty":-14.900412,"median":27.9469,"eighty":49.729928,"marketCap":10898685290},{"date":"2020-05-29","current":-1.146006,"twenty":-14.900412,"median":27.733111,"eighty":49.729928,"marketCap":10642957585},{"date":"2020-06-05","current":-1.476649,"twenty":-14.900412,"median":27.185707,"eighty":49.729928,"marketCap":13713642157},{"date":"2020-06-12","current":-1.219155,"twenty":-14.900412,"median":26.906303,"eighty":49.729928,"marketCap":11322295304},{"date":"2020-06-19","current":-1.166606,"twenty":-14.900412,"median":26.678555,"eighty":49.729928,"marketCap":10834265334},{"date":"2020-06-26","current":-1.057302,"twenty":-14.900412,"median":26.223249,"eighty":49.729928,"marketCap":9819162996},{"date":"2020-07-02","current":-1.081895,"twenty":-14.900412,"median":26.100817,"eighty":49.729928,"marketCap":10047561022},{"date":"2020-07-10","current":-1.035021,"twenty":-14.900412,"median":25.811921,"eighty":49.729928,"marketCap":9612238289},{"date":"2020-07-17","current":-1.060245,"twenty":-14.900412,"median":25.495623,"eighty":49.729928,"marketCap":9846492674},{"date":"2020-07-24","current":-1.123725,"twenty":-14.900412,"median":25.400075,"eighty":49.729928,"marketCap":10436032878},{"date":"2020-07-31","current":-1.066588,"twenty":-14.900412,"median":25.179654,"eighty":49.536695,"marketCap":10265909235},{"date":"2020-08-07","current":-1.040806,"twenty":-14.900412,"median":24.527679,"eighty":48.902121,"marketCap":10017761067},{"date":"2020-08-14","current":-1.040603,"twenty":-14.900412,"median":24.088548,"eighty":48.654643,"marketCap":10015807145},{"date":"2020-08-21","current":-0.984371,"twenty":-14.900412,"median":23.757593,"eighty":48.04925,"marketCap":9474570590},{"date":"2020-08-28","current":-1.060904,"twenty":-14.900412,"median":23.237709,"eighty":48.005982,"marketCap":10211199403},{"date":"2020-09-04","current":-1.02822,"twenty":-14.900412,"median":22.879248,"eighty":47.833642,"marketCap":9896617867},{"date":"2020-09-11","current":-0.919815,"twenty":-14.900412,"median":22.710048,"eighty":47.357651,"marketCap":8853223209},{"date":"2020-09-18","current":-0.976251,"twenty":-14.900412,"median":22.487665,"eighty":46.705482,"marketCap":9396413687},{"date":"2020-09-25","current":-0.887335,"twenty":-14.900412,"median":22.044459,"eighty":45.673114,"marketCap":8540595597},{"date":"2020-10-02","current":-0.874342,"twenty":-14.900412,"median":21.695329,"eighty":45.308472,"marketCap":8415544552},{"date":"2020-10-09","current":-0.914131,"twenty":-14.900412,"median":21.325904,"eighty":45.001416,"marketCap":8798513377},{"date":"2020-10-16","current":-0.986604,"twenty":-14.900412,"median":20.472618,"eighty":44.616144,"marketCap":9496063738},{"date":"2020-10-23","current":-0.951552,"twenty":-14.900412,"median":20.050952,"eighty":44.013784,"marketCap":9158686969},{"date":"2020-10-30","current":-0.788207,"twenty":-14.900412,"median":19.603963,"eighty":43.678027,"marketCap":8074392990},{"date":"2020-11-06","current":-0.804917,"twenty":-14.900412,"median":19.294145,"eighty":43.599353,"marketCap":8245567787},{"date":"2020-11-13","current":-0.972584,"twenty":-14.900412,"median":18.943416,"eighty":43.599353,"marketCap":9963151264},{"date":"2020-11-20","current":-1.090882,"twenty":-14.900412,"median":18.315824,"eighty":43.599353,"marketCap":11174991021},{"date":"2020-11-27","current":-1.177658,"twenty":-14.900412,"median":18.027808,"eighty":43.599353,"marketCap":12063932866},{"date":"2020-12-04","current":-1.22361,"twenty":-14.900412,"median":17.915245,"eighty":43.599353,"marketCap":12534663558},{"date":"2020-12-11","current":-1.201394,"twenty":-14.900412,"median":17.827972,"eighty":43.599353,"marketCap":12307078885},{"date":"2020-12-17","current":-1.169683,"twenty":-14.906009,"median":17.756409,"eighty":43.604534,"marketCap":11982235804},{"date":"2020-12-24","current":-1.091261,"twenty":-14.911606,"median":17.634394,"eighty":43.609716,"marketCap":11178881358},{"date":"2020-12-31","current":-1.106262,"twenty":-14.920934,"median":17.601937,"eighty":43.610988,"marketCap":11332549641},{"date":"2021-01-08","current":-1.237472,"twenty":-14.937462,"median":17.527755,"eighty":43.624979,"marketCap":12676660833},{"date":"2021-01-15","current":-1.325388,"twenty":-14.937462,"median":17.448879,"eighty":43.624979,"marketCap":13577273687}],"updateTime":1746442342891}}}